---
title: "How did clinical chemists respond to Elizabeth Holmes explanations? (Theranos)"
image: "https:\/\/i.ytimg.com\/vi\/RWIOggQZ5ns\/hqdefault.jpg"
vid_id: "RWIOggQZ5ns"
categories: "People-Blogs"
tags: ["bill clinton","futurama","hypnotoad"]
date: "2022-01-20T13:37:28+03:00"
vid_date: "2021-08-31T11:00:31Z"
duration: "PT29M18S"
viewcount: "374379"
likeCount: "6262"
dislikeCount: ""
channel: "SAWS"
---
{% raw %}A rare Q&amp;A between Elizabeth Holmes of Theranos and actual scientists from 2016.<br /><br />Sources<br /><br />American Association of Clinical Chemistry Presentation<br /><a rel="nofollow" target="blank" href="https://www.aacc.org/meetings-and-events/resources-from-past-meetings/theranos-presentation">https://www.aacc.org/meetings-and-events/resources-from-past-meetings/theranos-presentation</a><br />&quot;On August 1, 2016 at the 68th AACC Annual Scientific Meeting, Theranos CEO Elizabeth Holmes gave a presentation on her company’s technology. In this special session, Holmes discussed a compact instrument called “miniLab,” the inside of a cartridge-based testing system, video and description of micro-collection devices, and a concept called a virtual analyzer.<br />Following the presentation by Ms. Holmes, a moderator-led Q&amp;A session featured questions submitted in real-time by members of the audience. The moderator panel included 2016 AACC President Dr. Patricia Jones, and Drs. Y.M. Dennis Lo and Stephen Master.&quot;{% endraw %}
